Optimization of stability, encapsulation, release, and cross-priming of tumor antigen-containing PLGA nanoparticles. - sprookjes - yvandenbroek - TriplyDB

Optimization of stability, encapsulation, release, and cross-priming of tumor antigen-containing PLGA nanoparticles.

Optimization of stability, encapsulation, release, and cross-priming of tumor antigen-containing PLGA nanoparticles.

http://www.wikidata.org/entity/Q33821392

about

The era of bioengineering: how will this affect the next generation of cancer immunotherapy?A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei.In vitro controlled release of antigen in dendritic cells using pH-sensitive liposome-polymeric hybrid nanoparticles.Enhancement of anti-tumor effect of particulate vaccine delivery system by 'bacteriomimetic' CpG functionalization of poly-lactic-co-glycolic acid nanoparticles Non-invasive administration of biodegradable nano-carrier vaccines.Recruitment of bone marrow CD11b+Gr-1+ cells by polymeric nanoparticles for antigen cross-presentation.Recent progress towards development of a Shigella vaccine.Nucleic acid vaccination strategies against infectious diseases.Nanomedicine and cancer immunotherapy - targeting immunosuppressive cells.Controlled release of antigen and Toll-like receptor ligands from PLGA nanoparticles enhances immunogenicity.

P2860

Q33815087-4692003D-CC67-44BF-A2B5-84936B725526 Q35088366-16A5B014-2F14-4672-8819-ADA586C1E8F8 Q36326918-702A1DCA-542D-44B0-9216-49D9B00FB765 Q36822999-0BA760B1-AFA0-4F51-A4B7-2446561F6393 Q37596856-4E60D59E-1C34-4C65-8C4F-858A10111AB0 Q37710630-7070845E-E085-41D2-9D89-6B66B950E4E9 Q38068954-A25126B1-1C9A-43D5-8D86-50683A317AF5 Q38586079-A203E032-59DA-4EED-A338-358F27032FBF Q38603362-FB36ED7F-71A5-472A-AED3-03B4DCF11B62 Q51144432-2AA2BF0D-47A7-4E1F-B144-F9C3B2873D49

P2860

Optimization of stability, encapsulation, release, and cross-priming of tumor antigen-containing PLGA nanoparticles.

http://www.wikidata.org/entity/Q33821392

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Optimization of stability, enc ...... containing PLGA nanoparticles.

@ast

Optimization of stability, enc ...... containing PLGA nanoparticles.

@en

type

label

Optimization of stability, enc ...... containing PLGA nanoparticles.

@ast

Optimization of stability, enc ...... containing PLGA nanoparticles.

@en

prefLabel

Optimization of stability, enc ...... containing PLGA nanoparticles.

@ast

Optimization of stability, enc ...... containing PLGA nanoparticles.

@en

P1433

Q33821392-4A111E2A-614A-4197-8BFE-B1C557A3E350

P1476

Q33821392-EAD0CD2A-18AD-4F33-A843-6FD2B1694880

P2093

Q33821392-0B420FD5-1662-49D7-983D-A23084DF294A

Q33821392-3212EDB6-9AB4-46E9-91FD-5AF037E3DF07

Q33821392-70078D77-62C0-49A9-A5BC-268AFA27F91F

Q33821392-7BFA2000-B709-4E79-AA2D-2B2423C8C596

Q33821392-8AE6EE7F-DF49-4301-B4C4-16BC6D6CD861

Q33821392-C2CB3945-89FB-422F-87C8-73D4129A8A6E

P2860

Q33821392-14471DA1-F015-4B7E-9CCB-19C775E9E753

Q33821392-14DCFECD-E986-4F1A-B46E-012000CC8595

Q33821392-1B6A4BD3-34E7-47CD-988C-7DC91CCABDA1

Q33821392-1E24C4C7-1813-47FE-BF80-D88BDBD9D7CC

Q33821392-2D8D4D90-0904-4204-BF57-C4331FA5B57A

Q33821392-35A70E68-B1D6-4708-921F-ACFAC33BD418

Q33821392-3C484478-3FEB-4582-B138-367DFD32E129

Q33821392-51A8E4CB-055F-48AB-8535-87AE2E66FE7E

Q33821392-56D4E672-9A46-45C8-82E6-6A0EE548CA18

Q33821392-627A91C7-26E2-4DAC-B02D-C9C70DECA588

P304

Q33821392-B054BD80-D023-4E99-AD7A-397319F3168C

P31

Q33821392-0712F580-3D71-4BD6-A8E9-CCDBD2C1186C

P356

Q33821392-7EEA63E2-13D9-4E0C-B361-1B13EE4EE117

P433

Q33821392-083DED47-15E1-4118-9E76-8959A7CD6ECF

P478

Q33821392-C7A942A0-5F49-463C-A045-F8093B3743B2

P50

Q33821392-7C499642-1CF3-4F11-A84A-B5769BA6D3FC

P577

Q33821392-CD822F18-18A4-452F-B323-EF200FE3E9BA

P698

Q33821392-2D982D6D-34E1-4E23-9346-B47CFA2EF5E9

P932

Q33821392-ECFD5CB0-7AA9-4929-A79A-560CEDF4F574

P356

S11095-012-0787-4

P1433

Pharmaceutical Research

P1476

Optimization of stability, enc ...... -containing PLGA nanoparticles

@en

P2093

Douglas J Hanlon

http://www.w3.org/2001/XMLSchema#string

Jennifer K Saucier-Sawyer

http://www.w3.org/2001/XMLSchema#string

Martin A Birchall

http://www.w3.org/2001/XMLSchema#string

Richard L Edelson

http://www.w3.org/2001/XMLSchema#string

Shashi Prasad

http://www.w3.org/2001/XMLSchema#string

Virginia Cody

http://www.w3.org/2001/XMLSchema#string

P2860

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model.

Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres.

Preparation of alginate coated chitosan microparticles for vaccine delivery

Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination.

Strategies for stabilising tetanus toxoid towards the development of a single-dose tetanus vaccine.

Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems.

European union regulatory developments for new vaccine adjuvants and delivery systems.

Formulation aspects of biodegradable polymeric microspheres for antigen delivery.

Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.

P304

2565-2577

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11095-012-0787-4

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22798259

http://www.w3.org/2001/XMLSchema#string

P932

4075113

http://www.w3.org/2001/XMLSchema#string